Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
about
A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylationMAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinomaMetagenes associated with survival in non-small cell lung cancer.High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survivalOsteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.Identification of novel helper epitopes of MAGE-A4 tumour antigen: useful tool for the propagation of Th1 cells.CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.Identification of a novel CD8+ T cell epitope derived from cancer-testis antigen MAGE-4 in oesophageal carcinoma.MAGE-A9 mRNA and protein expression in bladder cancer.Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8(+) T-cell responses.Suppression of MAGE-A10 alters the metastatic phenotype of tongue squamous cell carcinoma cellsTrial Watch: Peptide vaccines in cancer therapy.T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice.MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas.
P2860
Q34087776-01BBB137-5810-4D09-A58F-8E30216511BFQ34196069-E8AE02BA-78DC-4AD1-9474-F9109AC9662EQ34340901-996F67A0-1CC1-4E50-9D91-BD2E094B5558Q35055017-709AC993-49BF-415A-830A-73FCEC9AC687Q35144956-05B772F0-7909-4687-AD56-CB8746A3843DQ36355935-8EB50EBD-73D6-4B86-964A-4CCFCC0F21DDQ36782607-DFBEB741-BE17-474B-9F71-047DEE6254AFQ37160648-2A6AB20C-9CDA-4415-A3B7-28066A0167C7Q38935082-73D34891-4FC0-4646-BE98-7E7BE2E4415EQ39495212-9DAB4784-73C8-46AB-A42F-0A112EB38B25Q40172793-415E5020-45C7-49CE-96D0-3CFB588C726CQ40953830-78525861-2D35-4579-9F74-9727F411AC12Q41682198-C740A420-8997-4A52-89CC-10B401A50CA2Q42734544-2A07D9ED-CC66-4E63-AAEA-61BF021B7788Q45873576-6FEAA4E1-5FA5-4DD8-863D-14317E45EA9CQ54284949-AEC3136E-63DE-472D-87DE-BC00445039D3
P2860
Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@ast
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@en
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@nl
type
label
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@ast
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@en
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@nl
prefLabel
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@ast
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@en
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@nl
P2093
P1476
Melanoma-associated antigens i ...... ovel MAGE-A10 splice variants.
@en
P2093
Dafydd G Thomas
David G Beer
Frank A Weishaar
Gregory S Robinson
Jeremy M G Taylor
Joel K Greenson
Mark B Orringer
Ruteja A Barve
P304
P356
10.1158/1078-0432.CCR-04-0468
P407
P577
2004-09-01T00:00:00Z